ClinicalTrials.Veeva

Menu

Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

Northwestern University logo

Northwestern University

Status

Completed

Conditions

Congestive Heart Failure

Treatments

Device: wearable vital signs sensor

Study type

Observational

Funder types

Other

Identifiers

NCT04362553
STU00210413

Details and patient eligibility

About

Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring

Enrollment

42 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  1. Patient's aged 18-65
  2. Patient's scheduled to undergo a Trans-thoracic Echocardiogram (TTE) in an outpatient cardiology clinic or admitted to the Cardiac Care Unit with a swan ganz catheter in place for continuous invasive hemodynamic monitoring

Exclusion Criteria

  1. Patient's with fragile skin or skin conditions that would prevent them from having a sensor placed
  2. Patients undergoing exercise or drug induced cardiac stress test
  3. Patients with a visible wound at site of sensor placement 3.4. Patients with structural or functional limitations to peripheral blood flow (known upper extremity peripheral arterial disease, use of vasopressors etc.).

Trial design

42 participants in 1 patient group

Adults
Description:
Adults scheduled to receive a TTE (Trans-esophogeal echocardiogram)
Treatment:
Device: wearable vital signs sensor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems